No abstract

No abstract

No abstract

The treatment of half of the women who used HT was terminated by doctors, while the other half chose to discontinue the therapy themselves due to their fear of cancer. The present study offers a significant insight into the barriers against HT for women in the menopausal period. Health professionals should inform women about evidence-based studies and implement an individualized treatment and health-care plan by sharing information with potential users.

No abstract